The Elias Group

Portfolio · 1

NeuroDerm

Drug-device Combination Solutions for Central Nervous System Disorders

1 round $16.0M committed Latest: 2014-08

Investment activity

1 portfolio exit on record.

Q&A

What is The Elias Group's primary investment focus by sector?

The Elias Group primarily focuses on the Health Tech & Life Sciences sector, with all of its portfolio companies and exits concentrated in this area.

Can you name a notable exit for The Elias Group?

A notable exit for The Elias Group is NeuroDerm, which went public on NASDAQ in November 2014 with a valuation of $164M.

When did The Elias Group make its most recent recorded investment?

The Elias Group's most recent recorded investment occurred in August 2014.

What is the typical investment range for The Elias Group?

The Elias Group's investment range is between $16M and $16M.

Which company is a key part of The Elias Group's portfolio?

NeuroDerm, a company focused on drug-device combination solutions for central nervous system disorders, is a key part of The Elias Group's portfolio.